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Abstract
Bovine spongiform encephalopathy (BSE) can be efficiently transmitted to pigs via intrace-
rebral inoculation. A clear link has been established between the consumption of products
of bovine origin contaminated with the BSE agent and the development of variant Creutz-
feldt-Jakob disease in humans. Small ruminants can also naturally develop BSE, and
sheep-adapted BSE (Sh-BSE) propagates more efficiently than cattle BSE in pigs and in
mouse models expressing porcine prion protein. In addition, Sh-BSE shows greater effi-
ciency of transmission to human models than original cow BSE. While infectivity and/or
abnormal PrP accumulation have been reported in the central nervous system in BSE-
infected pigs, the ability of the agent to replicate in peripheral tissues has not been fully
investigated. We previously characterized the presence of prions in a panel of tissues col-
lected at the clinical stage of disease from pigs experimentally infected with Sh-BSE. West-
ern blot revealed low levels of PrPres accumulation in lymphoid tissues, nerves, and skeletal
muscles from 4 of the 5 animals analysed. Using protein misfolding cyclic amplification
(PMCA), which we found to be 6 log fold more sensitive than direct WB for the detection of
pig BSE, we confirmed the presence of the Sh-BSE agent in lymphoid organs, nerves,
ileum, and striated muscles from all 5 inoculated pigs. Surprisingly, PrPres positivity was
also detected in white blood cells from one pig using this method. The presence of infectivity
in lymphoid tissues, striated muscles, and peripheral nerves was confirmed by bioassay in
bovine PrP transgenic mice. These results demonstrate the ability of BSE-derived agents to
replicate efficiently in various peripheral tissues in pigs. Although no prion transmission has
been reported in pigs following oral BSE challenge, our data support the continuation of the
Feed Ban measure implemented to prevent entry of the BSE agent into the feed chain.
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Introduction
Transmissible spongiform encephalopathies (TSE), or prion diseases, are progressive neurode-
generative disorders caused by the accumulation in the central nervous system (CNS) of PrPSc
(or PrPres), an abnormal isoform of the cellular prion protein (PrPC) [1]. While a substantial
transmission barrier usually limits interspecies propagation of prions, the agent of BSE has
shown an uncommon ability to propagate in other species. Since the BSE epidemics in cattle
[2], naturally occurring cases have been reported in a variety of zoo animals [3] and in farmed
goats [4–6]. BSE was also responsible for the emergence in humans of variant Creutzfeldt-
Jakob disease (vCJD), associated with the consumption of bovine products contaminated with
BSE prions [3, 7].
To prevent recurrence of this type of event, the concept of specific risk material (SRM) was
established, and many countries prohibited the inclusion of ruminant proteins in feed pro-
duced for cattle and other mammals. Moreover, several studies identified tissues outside the
CNS in which PrPres can be found. For example, in naturally infected cattle, prions have been
detected mainly in the brain, spinal cord, retina, and distal ileum [8–11]. In sheep with experi-
mentally-induced BSE, PrPres has been detected in the lymphoreticular system (LRS) [12], var-
ious portions of the digestive tract, and in some components of the peripheral nervous system
(PNS) [13, 14]. Peripheral accumulation of the BSE agent is thus more widespread in sheep
than in cattle, although BSE can be transmitted to other species without obvious alterations in
its neuropathological and biochemical features [7, 15, 16].
While pigs are susceptible to infection with the BSE agent following experimental parenteral
inoculation [17–19], a strong transmission barrier has been described [20], and no cases of natu-
ral TSE infections have been reported in pigs. In a transgenic mouse model expressing porcine
prion protein, the BSE agent can cross the cattle-pig transmission barrier more efficiently after
passage in sheep (Sh-BSE) [21]. Furthermore, we have shown that Sh-BSE prions propagate effi-
ciently in intracerebrally inoculated pigs, and that PrPres accumulation can be detected by
enzyme immunoassay and immunohistochemistry in a wide variety of peripheral tissues from
these animals [22]. However, conventional assays offer limited sensitivity, and may fail to detect
prions in tissues and fluids in which PrPres is present at very low levels. Here we describe a com-
parative protein misfolding cyclic amplification (PMCA) assay and mouse bioassay for the detec-
tion of PrPres in a panel of tissues collected from pigs intracerebrally inoculated with Sh-BSE.
To characterize the distribution of PrPres during clinical disease, we analysed different tis-
sues from Sh-BSE-inoculated pigs exhibiting clinical signs. Mouse bioassay revealed PrPres
infectivity in the CNS, PNS, skeletal muscle, and mesenteric lymph nodes. Moreover, the
PMCA technique allowed further amplification of PrPres in ileum, spleen, and white blood cell
(WBC) samples collected from Sh-BSE-inoculated pigs displaying clinical signs of disease.
Materials and methods
Ethics statement
All animal experiments were performed in strict accordance with European Community
Council Directive 86/609/EEC for the protection of animals used for experimental and other
scientific purposes and were approved by the relevant local ethics committees. The INRA/Tou-
louse ENVT Ethics Committee approved the experimental protocol in mice.
Sh-BSE in pig experimental cases
Tissue samples used in the present study were obtained from five minipigs that were experi-
mentally infected by intracerebral inoculation with the Sh-BSE agent [22]. These animals were
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challenged with 0.5 ml of a 10% brain pool obtained from BSE experimentally infected
sheep [23]. Intracerebral injections were performed through the frontal bone using a trephine
and a 20G × 2 ” needle and were carried out under general anesthesia. Sh-BSE challenged
pigs were monitored daily by animal husbandry staff, and veterinary clinical assessments were
performed weekly in order to evaluate their clinical status and determine the appearance of
signs that could seriously compromise the welfare of the animals. All challenged pigs showed
clinical signs of TSE between 77 and 109 weeks post inoculation, and the clinical picture
was characterized by early behavioral changes, followed by locomotor disability with progres-
sive ataxia and weakness. Animals were euthanized by intravenous pentobarbital injection
(DOLETHAL1; 10 mg/kg) followed by exsanguination when they showed any impairment in
their ability to stand up or any welfare-compromising clinical sign [22]. Details of individual
incubation periods, clinical signs and brain PrPSc detection are described in Hedman et al.,
2016.
Preparation of inocula
Samples of 7 tissue types (brain, brachial nerve, sciatic nerve, mesenteric lymph node, oculo-
motor muscle, ileum, and spleen) were collected from Sh-BSE-infected pigs [22] for PMCA
and mouse bioassays. In each case, disposable equipment (forceps and scalpels) was used to
manipulate the tissues, which were collected under TSE sterile conditions, precluding cross
contamination during sample preparation. Tissue inocula were prepared in sterile saline solu-
tion (1:10) in single-use micro tubes (Precess 48, BioRad) and were filtered using a syringe.
Tissue homogenates were then aliquoted and stored at -80˚C. Peripheral tissues and CNS
homogenates were prepared separately. Tissues from an uninfected pig were used as negative
controls.
Before sacrifice, whole blood was collected from the jugular vein of Sh-BSE-infected pigs,
using 10-ml tubes containing EDTA (ethylenediaminetetraacetic acid). Each tube was centri-
fuged continuously at room temperature for 15 min at 1,300 × g. The buffy coat fraction was
collected using a disposable hard-bulb pipette and mixed with 6 ml of PBS (phosphate buffered
saline). This mixture was then deposited over 3 ml of Lymphoprep solution (STEMCELL
Technologies) and centrifuged at 1,300 × g for 15 min. The WBCs obtained were then washed
3 times in PBS and aliquoted before freezing (-80˚C) and were subsequently analysed for prion
seeding activity and infectivity by PMCA and mouse bioassay, respectively.
Protein misfolding cyclic amplification
Mouse brain lysate from uninfected TgARQ mice was used as substrate for amplification of
Sh-BSE in pig prions. After sacrifice by CO2 exposure, mouse brains were rapidly removed
and washed twice in Ca++/Mg++ free PBS containing 5 mM EDTA. Brains were either used
immediately to prepare the PrPC substrate lysate or stored at -80˚C. The PrPC substrate (10%
brain lysate) was prepared using a Dounce tissue grinder to completely homogenize the brain
tissue in cold PMCA buffer (50 mM Tris-HCl, pH 7.4, 5 mM EDTA, 300 mM NaCl, 1% Triton
X-100). The substrate was left at 4˚C for 30 min, and then aliquoted and stored at -80˚C.
PMCA was performed by mixing 5 μl of seed with 45 μl of substrate per well in a 96-well
microplate (Axygen, Union City, CA, USA). One teflon bead (diameter, 2.381 mm) was added
to each well. PMCA seeds were serially diluted 10−1 to 10−11 fold in conversion buffer (final
volume, 100 μl). Next, 5 μl from the previous dilution was added to each well, which contained
45 μl of substrate. Microplates were placed in a sonicator (Misonix 4000) and subjected to 96
cycles of sonication (30 s of sonication, 30-min incubation at 37˚C) at 70% power. Three sub-
sequent rounds of PMCA were performed using a 1/10 dilution of the products of the previous
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PMCA round as the template. On completion of the PMCA procedure, aliquots from each
sample were collected for analysis of PrPres content.
Dot blot detection of PrPres
To determine the detection limit and sensitivity of the PMCA method used to amplify pig Sh-
BSE PrPres, dot blot was used to analyse the presence of PrPres in a 10-fold dilution series of
brain homogenate from one pig after 3 rounds of PMCA.
Each PMCA product (18 μl) was supplemented with 3% SDS and treated with proteinase K
(PK) (final concentration, 50μg/ml) for 1 h at 37˚C. Digestion was stopped by adding an equal
volume of Laemmli buffer and heating at 100˚C for 5 min. A 5-μl volume of sample was mixed
with 25 μl of 1% SDS. The samples were then vacuum transferred onto a nitrocellulose mem-
brane. The membrane was rinsed once with PBS (0.1% Tween 20) and incubated for 30 min in
PBS containing 2% BSA. The monoclonal antibody Sha31 (1:8000 in PBS+2% BSA), which
recognize residues 145–152 (YEDRYYRE) of PrP, was used for PrPres immunodetection [24].
Antibody binding was detected by incubating the membranes for 20 min with conjugated
mouse anti-goat IgG (1:5000; Santa Cruz Biotechnology). Immunoblots were developed by
enhanced chemiluminescence using ECL reagent (Pierce) and visualized using the Versa Doc
Quantity One image analysis system (Bio-Rad).
Bioassay
The mouse bioassay was performed in bovine PrP transgenic mice (tgBov/tg110) expressing
bovine PrPC at levels 8-fold higher than those detected in cow brain. TgBov mice are consid-
ered a highly efficient model for the detection of BSE infectivity [25]. At least 6 mice were
intracerebrally inoculated with each sample (20 μl). Mice were clinically monitored for the
onset of clinical signs of murine prion disease. Mice were euthanized when neurological dys-
function was evident, and they started to show locomotor disorders and/or any limitation in
their ability to feed. CNS and spleen samples were individually collected and subsequently ana-
lysed for PrPres.
Western blot detection of PrPres
The TeSeE Western blot kit (Bio-Rad) was used following the manufacturer’s recommenda-
tions. Samples taken from the brain, sciatic nerve, brachial nerve, mesenteric lymph node, ocu-
lomotor muscle, ileum, and spleen, and WBCs obtained from Sh-BSE-challenged pigs, were
analysed for the presence of PrPres. For PMCA products, 20 μl of reaction product was mixed
with 230 μl of 10% negative brain homogenate before PrPres extraction, as previously described
[26]. PrPres detection was performed using Sha31 mAb conjugated to horseradish peroxidase
(0.06 μg/ml). ECL substrate (Pierce) was used to reveal peroxidase activity.
Results
Using Western blot, we demonstrated PrPres positivity in the brains of all Sh-BSE-inoculated
pigs (Fig 1). The animals analysed in the present study were euthanized at 17, 26, and 27
months post-inoculation (mpi), and 2 more at 30 mpi (S1 Table) [22]. In some pigs, a positive
PrPres signal was observed in specific peripheral tissues, such as the oculomotor muscle and
ileum (Fig 2a and 2b). However, in others, no PrPres signal was detected in any of the periph-
eral tissues analysed (Table 1). No PrPres was detected in tissue samples from the negative con-
trol pig (Fig 2c). In all tissues analysed, we detected a predominance of the monoglycosylated
PrPres fraction (Figs 1 and 2); the WB electrophoretic pattern was therefore identical to that
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previously described in pigs, and similar to that described in transgenic mice expressing a pig
PrP amino-acid sequence [27].
Since the PrPres Western blot method is of limited sensitivity, we performed in vitro ampli-
fication by PMCA. This method allows amplification of minimal amounts of prion and has
been reported to be an efficient means of detecting the BSE agent in blood from vCJD patients
[28]. To assess the utility of this method for amplifying pig Sh-BSE and minute quantities of
PrPres, a 10-fold dilution series of brain homogenate (from P-1) was subjected to 3 successive
rounds of PMCA using brain homogenate from transgenic mice expressing the ovine ARQ
PrP as a substrate. After one round of PMCA, PrPres was detected in reactions seeded with a
10−3 dilution of the reference pig isolate. After 3 rounds of PMCA, PrPres was detected in reac-
tions seeded with a 10−9 dilution of the brain homogenate (S1 Fig). By contrast, the highest
dilution of brain homogenate for which a positive PrPres signal was detected by WB was the
10−3 dilution (S2 Fig). These results indicate that the PMCA method used is approximately 6
log10-fold more sensitive than direct WB for the detection of pig Sh-BSE prions.
After 3 rounds of PMCA, PrPres was detected in reactions seeded with all of the tissue sam-
ples, except for the mesenteric lymph node sample from P-3 (Fig 3). Unexpectedly, reactions
seeded with WBCs obtained from P-5 were also positive. (Figs 3 and 4a–4c). No PrPres was
detected in reactions seeded with tissue homogenates from the negative control pig, confirm-
ing the specificity of the technique. (Fig 4d). Based on the detection limit of PMCA after 3
rounds, seeding activity in peripheral tissues was between 8 log10 and 4 log10 lower than that
detected in brain tissue (Fig 3).
Parallel to PMCA, tissue homogenates from P-1 were also tested for infectivity by bioassay
in transgenic mice expressing bovine PrP (tgBov mice). The results confirmed the presence of
the Sh-BSE agent in the PNS, mesenteric lymph nodes, and oculomotor muscle in clinically
affected pigs. We observed lower attack rates (<100%) and/or more prolonged incubation
periods in tgBov mice inoculated with peripheral tissues than those inoculated with brain
homogenate. These results are consistent with the substantially lower infectivity in those tis-
sues than in the CNS (Table 2). No clinical disease or PrPres accumulation were observed in
Fig 1. Western-blot analysis to detect the proteinase K-resistant core fragment (PrPres) of the pathologic prion in
the brain of 5 pigs experimentally infected with Sh-BSE. PrPres western-blot profile from the original Sh-BSE isolate,
characterized by predominance of the diglycosylated band, is shown for comparison. Immunodetection was
performed using the monoclonal Sha31 antibody. A PK digested classical scrapie isolate (Dawson strain) was used as
positive control (Control).
https://doi.org/10.1371/journal.pone.0199914.g001
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Fig 2. Detection of PrPres in the brain and peripheral tissues of Sh-BSE-inoculated pigs with clinical disease. (a) A
strong PrPres signal is detected in the brain of one pig sacrificed at 17 months post inoculation (mpi), whereas a much
weaker signal is observed in oculomotor muscle and ileum samples from the same animal. (b) PrPres detection in brain
and oculomotor muscle samples from a pig sacrificed at 30 mpi. (c) No PrPres was detected in tissues from the negative
control pig. Immunodetection was performed using the monoclonal Sha31 antibody. Control: PK digested classical
scrapie isolate.
https://doi.org/10.1371/journal.pone.0199914.g002
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mice inoculated with spleen, ileum, or WBC samples from P-1, or in mice inoculated with
control brain homogenate.
Discussion
In the present study, we used a modified PMCA amplification protocol [29], and a mouse
infectivity bioassay to examine the distribution of prions in peripheral tissue in 5 pigs follow-
ing intracerebral challenge with sheep-passaged BSE agent [22].
In the 5 challenged pigs, PrPres accumulation in the CNS was confirmed by WB (Fig 1). In
line with all published BSE transmission experiments in pigs or transgenic mice expressing pig
PrPC [20–22, 30], the PrPres WB pattern revealed predominance of the monoglycosylated
PrPres moiety. In peripheral tissues, some variation in PrPres detection was observed between
animals. Direct WB revealed the presence of PrPres in oculomotor muscle and ileum samples
from a pig sacrificed at 17 mpi, but only in oculomotor muscle in a pig that succumbed to
disease at 30 mpi (Fig 2). These results suggest that, in Sh-BSE clinically affected pigs, there is
no apparent correlation between the incubation period and peripheral PrPSc dissemination.
After 3 rounds of PMCA, some degree of variation in seeding activities in peripheral tissues
was also observed between pigs (Fig 3 and S1 Table). Moreover, PrPres in peripheral tissues
was detected in reactions seeded with tissue homogenates diluted at 10−1 to 10−4, but in reac-
tions seeded with brain homogenate at dilutions of 10−8–10−9 (S1 Fig). Thus, in Sh-BSE
infected pigs, the accumulation of prions was significantly greater in the brain than in periph-
eral tissues, in which PrPres accumulation was more restricted, and varied considerably
between animals. This heterogeneous accumulation of PrPres in peripheral tissues may be par-
tially explained by tissue sampling, since there is a reported variation in PrPres concentration
between different tissue regions depending on the absence or presence of embedded nerve
endings or individual lymphoid follicles, as described in cattle with BSE [31, 32].
No false positive reactions were observed, and the specificity of the technique was demon-
strated by the absence of detectable PrPres after 3 rounds of PMCA of a diluted sample of brain
homogenate from an uninfected pig (Fig 4d). As mentioned above, the PMCA protocol used
allowed detection of PrPres after 3 rounds in reactions seeded with a 10−9 dilution of brain
homogenate, a similar sensitivity to that previously described, using the same protocol, for pig
adapted BSE and other BSE-derived strains [28].
Bioassays were performed using tgBov mice, which are highly susceptible to propagation of
the BSE agent [25]. Survival times for tgBov mice inoculated with brain homogenate from Sh-
BSE-infected pigs (306 ± 81 dpi) were similar to those previously described for tgBov mice
inoculated with pig-adapted BSE [27].
To our knowledge, this is the first report demonstrating the infectivity in a mouse bioassay
of sciatic and brachial nerves, skeletal muscle (oculomotor), and mesenteric lymph nodes from
Table 1. Western blot detection of PrPres in the original inocula prepared with tissues collected from Sh-BSE-inoculated pigs with clinical disease.
ID Brain Sciatic nerve Brachial nerve Mesenteric lymph node Exocular muscle Ileum Spleen WBC
P-0 - - - - - - - ND
P-1 + - - - + + - ND
P-2 + - - - - - - ND
P-3 + + - - + + + ND
P-4 + - - - - + - ND
P-5 + - - - + - - ND
Negative:—Positive: + No determined: ND
https://doi.org/10.1371/journal.pone.0199914.t001
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Fig 3. Relative performance of protein misfolding cyclic amplification of porcine Sh-BSE using brain tissue from
ARQ/ARQ ovine PrP transgenic mice as substrate. PMCA reactions were seeded with a 10-fold dilution series (10−1–
10−11) of 8 different tissues collected from 5 Sh-BSE-infected pigs. For each tissue, the last PrPres-positive dilution as
detected by Western blot after 1 (white), 2 (grey), and 3 (black) consecutive amplification rounds (96 cycles in a Misonix
4000 sonicator) is shown. The following tissues were assayed: brain, sciatic nerve, brachial nerve, mesenteric lymph
node, extraocular muscle, ileum, spleen, and white blood cells.
https://doi.org/10.1371/journal.pone.0199914.g003
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Fig 4. PrPres detection in PMCA reactions seeded with tissue samples collected from a Sh-BSE clinically affected
pig. Tissues: brain, sciatic nerve, brachial nerve, mesenteric lymph node, oculomotor muscle, ileum, spleen, and white
blood cells (WBC). The animal was culled at 30 months after intracerebral inoculation with Sh-BSE. After 3 rounds of
PMCA (48 hours each), PrPres amplification was detected at dilutions of 10−1 (a) and 10−2 (b) in all the tissues analysed.
No PrPres was amplified in the mesenteric lymph node, ileum, or spleen at a dilution of 10−3 (c). Results obtained for
Peripheral distribution of prions in pigs infected with sheep-passaged bovine spongiform encephalopathy agent
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pigs intracerebrally inoculated with BSE-derived agents. In a previous study, we evaluated the
neuropathology and distribution of Sh-BSE prions in intracerebrally inoculated pigs with clini-
cal disease. Using immunohistochemistry, we demonstrated the presence of Sh-BSE prions in
the nervous components of a variety of peripheral tissues, including nerve fibres of the oculo-
motor muscle, the myenteric plexi of the gastrointestinal tract, retinal ganglion cells, and the
postganglionic neurons of the adrenal glands and pancreas [22]. The specific location of PrPSc
in these tissues, together with the results obtained in the present study, suggests a centrifugal
spread of the agent from the CNS to the organs via the PNS. However, in one infected animal
we also observed PrPSc deposition in the epithelial tubular cells and the collecting ducts of the
kidney in the absence of nephritis [22]. This localization of PrPSc aggregates in renal tissues
suggests the arrival PrPSc to this organ via the blood [33]. Given that we also detected prion
seeding activity in WBCs from one animal, we cannot rule out the possibility that prions are
also haematogenously disseminated in Sh-BSE-infected pigs. In previous studies in which the
BSE agent was transmitted to pigs, mouse bioassay revealed infectivity in the CNS, stomach,
jejunum, ileum, and pancreas of animals sacrificed in the terminal stage of the disease [17, 19,
34]. However, those animals were simultaneously inoculated via intracerebral, intraperitoneal,
and intravenous routes. As such, no solid conclusions can be reached as to the spread of prions
to these tissues, since the presence of infectivity could be the result of persistence of intraperi-
toneally injected inoculum [35] or local replication of the agent [36].
The low attack rates and/or extended incubation times observed in mice inoculated with
brachial nerve, mesenteric lymph node, and ileum samples suggests a low titre of infectivity in
these tissues. These results are consistent with the low conversion efficiency of PMCA reac-
tions seeded with those same tissues as compared with that observed in reactions seeded with
brain homogenate (Fig 3). In contrast to the negative results obtained in the bioassay, PMCA
allowed detection of PrPres in reactions seeded with a 10−2 dilution of spleen and ileum tissue
from P-1. While neither seeding activity nor infectivity was observed for WBCs from P-1,
PrPres was detected in reactions seeded with WBCs from P-5 at a 10−3 dilution after 3 rounds
of PMCA. Thus, these results represent an evidence for prionaemia [37] in pigs experimentally
infected with BSE-derived agents. It has been previously demonstrated that prion diseases can
be efficiently transmitted by blood transfusion [38], and that WBC are appropriate targets for
prion detection in scrapie [39], BSE, and vCJD, even in preclinical disease stages [40, 41].
We have shown that Sh-BSE is efficiently transmitted to pigs after intracerebral inoculation,
and that PrPSc in inoculated animals is widely distributed in a variety of peripheral tissues [22].
We show that PrPres is also present in tissues in which prion deposition is not detected by con-
ventional techniques and, for the first time, we demonstrate the detection of BSE-derived
agents in the blood of prion-infected pigs. The ability of pig-adapted prions to accumulate in
10−1 dilution after 3 rounds of PMCA in reactions seeded with tissues from a negative control pig (d). Control: PK
digested classical scrapie isolate.
https://doi.org/10.1371/journal.pone.0199914.g004
Table 2. Intracerebral inoculation of tgBov mice with a panel of tissues collected from a Sh-BSE clinically affected pig.
Inocula Brain Sciatic nerve Brachial nerve Mesenteric lymph node Oculomotor muscle Ileum Spleen WBC
Positive micea 5/5 5/6 2/6 1/5 5/5 0/5 0/5 0/5
Incubationb 306±85 402± 76 478±0 477 412 ±86 - - -
a Data based on PrPres detection in the brain
b Incubation periods were calculated as the number of days between inoculation and the onset of clinical signs consistent with a prion disease, at which time mice were
euthanized. Incubation periods are shown as mean±SEM days post-inoculation
https://doi.org/10.1371/journal.pone.0199914.t002
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peripheral tissues and blood components may have important implications, given the broad
range of pig-derived food products, being blood the main constituent of some of them. How-
ever, it is important to bear in mind the limitations associated with intracerebral inoculation,
since the route of infection, together with PRNP genotype and prion strain is one of the key
factors controlling the transmission barrier. Compared with intracerebral inoculation, infec-
tion via the oral route, which accounts for the majority of natural infections, is generally a
much less efficient means of transmitting the disease [42]. In addition to the lack of natural
TSE cases reported in pigs, attempts to orally transmit BSE to pigs have been unsuccessful
[34]. However, it should be considered that Sh-BSE has been reported to have an increased
pathogenicity compared to cattle BSE in studies using transgenic mice expressing porcine [21]
or human PrP [43, 44]. In addition, it has been demonstrated that sheep infected with the BSE
agent show a significantly wider tissue distribution of both PrPSc and infectivity than BSE-
infected cattle [9, 11, 45–47]. In the present study, we have detected the Sh-BSE agent in a wide
variety of extraneural tissues. Sh-BSE prions also seem to present a wider tisular spread than
cattle BSE in the porcine species, [22], although both agents are intracerebrally transmitted to
the pig with a similar incubation period [22, 34]. Therefore, despite infructuous attempts to
orally transmit cattle BSE to pigs, it should not be ruled out that Sh-BSE could be transmitted
to the porcine species via the oral route, and it should be considered that the agent may be
present in a greater number of tissues. Considering that natural BSE cases have been described
in small ruminants [6, 48] and given that Sh-BSE, as aforementioned, propagate more effi-
ciently than cattle BSE in human PrP transgenic mice [43], we consider that further studies of
oral exposure of pigs to Sh-BSE will be necessary to determine the potential risk of natural
transmission in this species.
In summary, our results reinforce the view that despite a significant transmission barrier,
BSE can replicate in the peripheral tissues of pigs exposed to BSE agent. Taken together with
the results of previous studies, these data support the continuation of the Feed Ban imple-
mented to prevent the entry of BSE agent into the feed chain.
Supporting information
S1 Fig. PrPres detection by dot blot in PMCA reactions seeded with serially diluted (10−1–
10−10) brain homogenate from a Sh-BSE-infected pig. After 3 rounds of PMCA, PrPres was
amplified in reactions seeded with a 10−9 dilution of a brain homogenate from the Sh-BSE-
infected pig, demonstrating the sensitivity of the PMCA protocol used to detect pig Sh-BSE
prions. The monoclonal Sha31 antibody was used for immunodetection.
(TIF)
S2 Fig. Western-blot detection of PrPres in serially diluted brain homogenates (10−1–10−5)
from Sh-BSE-infected pigs. Western blot allowed detection of PrPres present in dilutions
(10−1–10−3) of the original homogenates before PMCA. The monoclonal Sha31 antibody was
used for immunodetection. MM: Magic Marker.
(TIF)
S1 Table. Individual survival periods and detection limits of Western blot and PMCA for
brain samples of Sh-BSE inoculated pigs.
(PDF)
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Writing – original draft: Carlos Hedman, Alicia Otero, Caroline Lacroux, Hicham Filali, Juan
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